PER percheron therapeutics limited
Add to My Watchlist 0.00% ! 1.0¢

Ann: Change of Interest of Substantial Holder from PVL, page-4

  1. makka
    1,976 Posts.
    lightbulb Created with Sketch. 236
    clock Created with Sketch.
    17/01/25
    09:22
    Post #: 77442000
    Just based on cash backing it’s way undervalued, if this becomes a back door listing for another drug then it will fly and that’s what think is happening , hence the sub holder is increasing their holdings.
    PER Price at posting: 0.8¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $1.94K 194K

Buyers (Bids)

No. Vol. Price($)
1 4012871 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3174000 4
View Market Depth
Last trade - 11.55am 17/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.